Increased antibody titers and reduced seronegativity following fourth mRNA COVID-19 vaccination in patients with cancer

Cancer Cell. 2022 Aug 8;40(8):800-801. doi: 10.1016/j.ccell.2022.06.012. Epub 2022 Jul 1.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • COVID-19 Vaccines
  • COVID-19* / prevention & control
  • Humans
  • Neoplasms*
  • RNA, Messenger
  • Vaccination

Substances

  • COVID-19 Vaccines
  • RNA, Messenger